Riyadh — Mubasher: Nahdi Medical Company logged a net profit of SAR 171.80 million for the third quarter (Q3) of 2026, up 6.58% from SAR 161.20 million in Q3-25.
The revenues surged by 9.36% to SAR 2.69 billion, supported by robust performance in the retail sector and accelerated growth in healthcare services.
Operating profit for the quarter rose by 4.42% to SAR 195.90 million. The company attributed the results to a 9.40% increase in total sales, though gross profit margins narrowed to 35.50% from 38.20% due to shifts in the business mix and continued investments in digital transformation and e-commerce platforms.
In the nine-month period that ended on 30 September 2026, the net profit hit SAR 622.70 million, a decrease of 4.90% compared to SAR 654.8 million in the previous year.
Total revenue for the first nine months grew by 7.04% to SAR 8.16 billion.
The pharmacy chain operator noted that nine-month earnings per share (EPS) was SAR 4.79, while total equity increased by 7.15% to SAR 2.70 billion.
During Q2-36, Nahdi Medical posted a 9.73% YoY drop in net profit to SAR 215.20 million.
The group currently operates 1,219 pharmacies and 15 primary healthcare clinics across 10 major cities.
